Aurinia Pharmaceuticals Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aurinia Pharmaceuticals Inc. reported Cash And Cash Equivalents At Carrying Value of $80.16 million for the year ending 2025.

  • Aurinia Pharmaceuticals Inc. showed a decrease of -3.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Aurinia Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Aurinia Pharmaceuticals Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 73.8%.
  • Historical annual values: Fiscal year 2025: $80.16 million | Fiscal year 2024: $83.40 million | Fiscal year 2023: $48.76 million | Fiscal year 2022: $94.09 million | Fiscal year 2021: $231.64 million | Fiscal year 2020: $272.35 million | Fiscal year 2019: $306.02 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: